Pivotal Point Tracking Haemonetics (HAE): Comeback of CSL Plasma and Strong Q1 Numbers Ignite Pivotal Point
Reading Time: 1 minute
Haemonetics is a leading provider of innovative medical technology for blood and plasma donation, operating rooms, and vascular closure systems. On August 18, the stock surged under high trading volume from $90.27 to over $104.65. The catalyst was a new US supply agreement with CSL Plasma for NexSys-PCS devices featuring Persona-PLUS technology. The recovery of this important key customer alleviates a long-standing burden on the business and secures recurring revenues from consumables. Additionally, the recently surpassed Q1 numbers and an upgraded...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
